Progression-free and overall survival for concurrent nivolumab with standard concurrent chemo-radiotherapy in locally advanced stage IIIA/B NSCLC: Results from the European Thoracic Oncology Platform NICOLAS phase II trial (ETOP 6-14).
Peters, S., Felip, E., Dafni, U., Tufman, A., Guckenberger, M., Ãlvarez, R., Nadal, E., Becker, A., Vees, H., Pless, M., Martinez-Marti, A., Lambrecht, M., Andratschke, N., Tsourti, Z., Piguet, A.-C.Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2020.10.129
Date:
November, 2020
File:
PDF, 1.31 MB
2020
File converter
More search results
More benefits 
